K2 Principal Fund’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,884
| Closed | -$112K | – | 226 |
|
|
2018
Q3 | $112K | Sell |
11,884
-8,707
| -42% | -$82.1K | 0.01% | 236 |
|
|
2018
Q2 | $150K | Sell |
20,591
-130,487
| -86% | -$951K | 0.01% | 228 |
|
|
2018
Q1 | $755K | Sell |
151,078
-110,248
| -42% | -$551K | 0.04% | 163 |
|
|
2017
Q4 | $1.32M | Buy |
261,326
+11,311
| +5% | +$57.1K | 0.1% | 124 |
|
|
2017
Q3 | $1.55M | Sell |
250,015
-125,839
| -33% | -$780K | 0.1% | 102 |
|
|
2017
Q2 | $1.35M | Sell |
375,854
-52,113
| -12% | -$188K | 0.09% | 116 |
|
|
2017
Q1 | $1.39M | Sell |
427,967
-15,920
| -4% | -$51.7K | 0.12% | 94 |
|
|
2016
Q4 | $1.09M | Buy |
443,887
+336,267
| +312% | +$824K | 0.1% | 83 |
|
|
2016
Q3 | $370K | Buy |
107,620
+44,070
| +69% | +$152K | 0.04% | 112 |
|
|
2016
Q2 | $221K | Buy |
63,550
+33,796
| +114% | +$118K | 0.03% | 141 |
|
|
2016
Q1 | $123K | Buy |
+29,754
| New | +$123K | 0.02% | 101 |
|
|
2015
Q4 | – | Sell |
-37,135
| Closed | -$226K | – | 110 |
|
|
2015
Q3 | $226K | Sell |
37,135
-5,500
| -13% | -$33.5K | 0.04% | 84 |
|
|
2015
Q2 | $506K | Buy |
+42,635
| New | +$506K | 0.09% | 87 |
|
|
2015
Q1 | – | Sell |
-12,735
| Closed | -$193K | – | 99 |
|
|
2014
Q4 | $193K | Buy |
+12,735
| New | +$193K | 0.05% | 86 |
|